The ability to see the world around us is a gift that’s easy to take for granted, until it’s threatened by the onset of a devastating eye disease. For those facing the reality of vision loss, ophthalmic research represents a beacon of hope, offering the promise of new treatments and therapies to preserve or restore
18.01
2017
Analyzing Choroidal Neovascularization (CNV) in pigs: Saline vs. Eylea™
In the experiment above, pigs received six laser shots per eye, with the control group receiving saline treatment and test group receiving Eylea™ treatment. Eylea™, an FDA-approved drug, is an anti-vascular endothelial growth factor (anti-VEGF) that prevents vascular growth. The crisp, high resoution brightfield and fluorescein angiography images, captured by the Micron X, show that Eylea™ clearly mitigates the neovascularization induced by laser burn.